ArticleBMC cancer2024

Prognostic factors and risk-stratification model of recurrent or metastatic head and neck squamous cell carcinoma treated with cetuximab containing regimen.

Muh-Hwa Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.